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Use of Twins to Study Environmental
Effects
by Joe C. Christian*
Extrapolation from pharmacogenetic studies would indicate that there is a great deal of
genetic variability in the response of humans to noxious environmental agents. Co-twins
provide the most closely matched genetic controls possible and, in addition, are matched
perfectly for age and often have shared very similar environments since before birth. The
efficiency of co-twin control studies can be further increased by the use of sequential analysis,
so that for the studies of the effects of environmental agents on human populations, twins
would give answers that would require many more unrelated subjects. Use of twins in
epidemiology studies is now in its infancy, but investigators should carefully consider the use of
this powerful experimental tool and begin to identify twins in population surveys.
Introduction
Human experimentation is faced by ever-
increasing costs, more competition for available
resources and the ever-present need to protect the
experimental subjects from unnecessary risks. To
counter these forces, extreme care must be taken
to select the most powerful and efficient experi-
mental designs for human epidemiological research.
This paper explores the co-twin control model
for use in epidemiological studies as an extremely
efficient method of selecting controls which are
matched genetically and environmentally as well
as being the same age. Coupling paired compari-
sons of twins with sequential analysis is proposed
as the most efficient method of studying low dose
effects of environmental agents on human popula-
tions.
Background
Twins have been used in human experimenta-
tion for over one hundred years. The comparison
of monozygotic (MZ) twins with dizygotic (DZ)
twins has been used frequently to estimate genetic
variance or heritability. The MZ within-pair mean
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square, for example, contains no genetic variance
because MZ twins are genetically identical. The
DZ within-pair contains one-half of population
additive genetic variance. The difference between
these mean squares (MWDZ - MWMZ) is, therefore,
an estimate of one-half population genetic vari-
ance. An area in which twin studies have been
used almost exclusively to estimate genetic vari-
ance is the field ofpharmacogenetics. Propping (1)
reviewed studies of 11 drugs, all studied in twins
and all showing a large amount ofgenetic variabil-
ity in the rate of metabolism.
Brewer (2) coined the term, ecogenetics, by
generalizing that genetic variation not only was
relevant to drug action but needed to be consid-
ered in the human response to any kind of envi-
ronmental agent. Because most of the environ-
mental agents of concern have been implicated in
teratogenesis, mutagenesis, carcinogenesis or the
genesis of other diseases it is not feasible in many
instances to do experimental studies of these
substances in man. Therefore, observational or
epidemiological studies are of prime importance.
Twins have just begun to be used in epidemio-
logical studies. Leadership in this field has been
taken by the National Heart, Lung and Blood
Institute's Epidemiology Branch and the collabo-
rative study of heart disease risk factors (3) by
using the National Academy of Sciences National
Research Council panel of World War II veteran
twins (4).
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For most traits ofimportance in medicine, there
is marked variability among individuals. In the
most simple terms, this variability can be ascribed
to genetic factors, environmental factors or an
interaction between genes and environment. This
inherent variability often obscures the effects of
environmental influences by overwhelming them
with background noise or experimental error and
makes the choice of appropriate controls critical.
Table 1 shows how co-twin control studies can be
used to control much of this experimental error.
The MZ within-pair mean square, for example,
contains no genetic variance, which precludes the
possibility of genetic-environmental variation and
contains only a fraction of population environmen-
tal variance, inversely related to the environmen-
tal covariance of MZ twins. Because the twins
share the same environment throughout gestation
and often very similar environments after birth,
this covariance often makes up a considerable
portion of environmental variance making MZ
twins often "as alike as two peas in a pod."
Dizygotic twins, while not genetically identical,
may also be used in co-twin control studies, and,
while less concordant than MZ twins, are in most
cases much more alike than age- and sex-matched
controls often used in epidemiological studies.
Dizygotic twins are also useful in studying the
associations between genetic markers and disease
states or risk factors (6).
There are several experimental situations for
which co-twin control studies are suited. Histori-
cally, the most commonly used co-twin control
study is a clinical trial in which the two members
of twin pairs are assigned randomly to two treat-
ments or a treatment and a control. Twins are
especially suited for long-term clinical trials where
environmental trends are important and for stud-
ies in which carryover effects preclude the use ofa
crossover design. A second potential use for twins
is in population surveys in which exposure history
to an environmental factor is to be correlated with
a disease endpoint. Twins can be ascertained as
part of any population survey and then an appro-
priate sample chosen based upon exposure history
with the co-twin serving as a built-in control.
In any proposed co-twin control study the added
expense of obtaining twins must be compared to
the expected advantage of using twins. It is often
relatively inexpensive to ascertain twins which
account for about 1% of the births in this country
and therefore, one in fifty individuals. In addition,
a recent review (7) revealed 21 active twin panels
in the United States and Canada in addition to the
resources for zygosity diagnosis available in virtu-
ally every state through clinical genetics units (8).
The simple procedure ofadding the question, "Are
you a twin?" to population surveys would often
provide a wealth ofresponses from which to select
appropriate twin pairs for study.
The number of twin pairs needed to test a
hypothesis can be calculated given an estimate of
within twin-pair variability for the trait in ques-
tion and the size of the difference to be detected.
A method is available for estimating the number of
twin pairs needed by using uniformity trials in
which data from twin pairs not subjected to
treatment are used to estimate the experimental
errors ofa completely randomized clinical trial and
a co-twin control study (9). The within-pair varia-
tion (MWMZ) is an estimate of the co-twin control
Table 1. Analysis ofvariance model for twin studies.a
Source of variation df Mean squares Expected value of mean square
Monozygotic twins
Among pairs nmZ-1 MAMZ 2ca2 + 2ad2 + 2c(i2 + ore2 + 4age + CMZ
Within pairs nMZ MWMZ a2 - CMZ
Dizygotic twins
Among pairs nDZ-l MADZ 3/2aa2 + 5/4ad2 + (1 + f)ai2 + ae2 + 2(oage + af*ge) + CD
Within pairs nDZ MWDZ 1/2aa2 + 3/4 ad2 + (1 -f) Ci2 + ae2 + 2(aJge -r*ge) - CDZ
anMZ = number of monozygotic twin pairs; nDZ = number of dizygotic twin pairs; df = degrees of freedom; aa2 = variance
componentduetoadditivegeneticeffects; ad = variancecomponentduetodominantgeneticeffects;Cri2 = variancecomponentdueto
epistaticgeneticeffects; ae = variancecomponentduetoenvironmentaleffects;age = covariancebetweengeneticandenvironmental
effectsinthe sameindividual; a* e = covariance betweengeneticeffectsononememberofatwinpairandenvironmental effectsonthe
othermemberofthattwinpair;C'M = covarianceamongenvironmentaleffectsbetweenpairsofmonozygotictwins;CDZ = covariance
among environmental effects between pairs ofdizygotic twins; andf = one minus the fraction ofepistatic variance manifest within
dizygotic twin sets. After Christian et al. (5).
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FIGURE 1. Schematicrepresentation ofarestricted sequentiaI
design for normally distributed measurements with known
variability (12).
study experimental error. The among- and within-
pair mean squares are used to obtain an estimate
ofexperimental error for single-born individuals in
the same population [(MAMZ - Mwmz)/2]. In this
paper a nomogram is presented that allows the
investigator to calculate the relative numbers of
unrelated individuals and twins needed. This no-
mogram takes into consideration the relative sizes
of the experimental errors and the relative de-
grees of freedom because a co-twin control study,
like any paired comparison, has fewer degrees of
freedom than a completely randomized design. A
comparison of the relative efficiencies of matched
pair studies with co-twin control studies is simpler
because the degrees of freedom are comparable
and the only additional information needed is an
estimate of how much variability is controlled by
the matched pairs as compared to twins plus an
estimate of the difficulty of obtaining matched
controls versus twins.
It has recently been proposed that another
magnitude of efficiency can be obtained by cou-
pling co-twin control studies with sequential anal-
ysis (10). Sequential analysis was developed in the
early 1940's and its use in clinical trials has been
reviewed by Armitage (11). In sequential analysis
the results are analyzed continuously and a deci-
sion made whether to continue or discontinue the
trial with each analysis. This method has extreme
appeal for human studies which are often con-
ducted serially as appropriate subjects are ascer-
tained. Figure 1 shows a model of a sequential
analysis after Schneiderman and Armitage (12).
This model is for normally distributed measure-
ments with known variability and with no prior
expectation of which treatment will result in the
greater values for the variable being studied. The
number of twin pairs to be studied (N) is first
estimated, and then twin pairs are studied serially
with one member being assigned at random to
each oftwo treatments. The sum ofthe differences
is plotted (treatment A minus treatment B), and if
this sum crosses the upper boundary, treatment A
is judged to cause a higher value than treatment
B. The reverse is true if the lower boundary is
crossed. The upper and lower boundaries are
generally set at ot levels of 0.05 or 0.01. Crossing
the middle boundary, generally set at a much
lower a, value than the upper or lower boundaries,
indicates that continuation ofthe experiment gives
little possibility of rejecting the null hypothesis.
Therefore, crossing any of the boundaries results
in termination of the experiment. It is not unreal-
istic to expect that on the average sequential
analysis would reduce the number of experimental
subjects needed by one half. In general, sequential
analysis will add maximum efficiency in short-term
studies or longer studies in which experimental
subjects are ascertained over a relatively long
period of time. There are series of sequential
models well suited to various experimental condi-
tions. Ifthe study involves, for example, a popula-
tion survey of environmental exposure and its
relationship to another quantitative variable, the
appropriate statistic could be the correlation be-
tween twin differences for the environmental
influence and the twin differences for the trait
being studied. In addition sequential designs are
well suited for use qualitative traits that are either
present or absent.
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